IMAX CORP (IMAX)

GELFOND RICHARD L 🟡 adjusted position in 120.1K shares (3 derivative) of IMAX CORP (IMAX) at $37.15 ($12.0M) Transaction Date: Apr 13, 2026 | Filing ID: 004708

Register to leave comments

  • News bot April 15, 2026, 10:08 p.m.

    🔍 GELFOND RICHARD L (Executive)

    Company: IMAX CORP (IMAX)

    Report Date: 2026-04-13

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 3
    • Holdings reported: 1
    • Total shares acquired: 120,132
    • Total shares sold: 240,264
    • Total shares held: 765,002

    Detailed Transactions and Holdings:

    • Acquired 97,462 shares of common shares at $31.4 per share (Direct)
      Date: 2026-04-13 | Code: C | equity_swap_involved: false | shares_owned_after: 862,464.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 97,462 shares of common shares at $37.1526 per share (Direct)
      Date: 2026-04-13 | Code: S | equity_swap_involved: false | shares_owned_after: 765,002.00 | transaction_form_type: 4
    • Acquired 6,924 shares of common shares at $31.4 per share (Direct)
      Date: 2026-04-14 | Code: C | equity_swap_involved: false | shares_owned_after: 771,926.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,924 shares of common shares at $37.0678 per share (Direct)
      Date: 2026-04-14 | Code: S | equity_swap_involved: false | shares_owned_after: 765,002.00 | transaction_form_type: 4
    • Acquired 15,746 shares of common shares at $31.4 per share (Direct)
      Date: 2026-04-15 | Code: C | equity_swap_involved: false | shares_owned_after: 780,748.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 15,746 shares of common shares at $37.0707 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: false | shares_owned_after: 765,002.00 | transaction_form_type: 4
    • Holds 0 shares of common shares (opening balance) (Direct)
      Date: 2026-04-13 | Code: H | shares_owned_after: 765,002.00
    • Sold 97,462 shares of stock options (to buy) at $31.4 per share (Derivative)
      Date: 2026-04-13 | Code: C | Expires: 2026-06-07 | equity_swap_involved: false | shares_owned_after: 1,439,943.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4
    • Sold 6,924 shares of stock options (to buy) at $31.4 per share (Derivative)
      Date: 2026-04-14 | Code: C | Expires: 2026-06-07 | equity_swap_involved: false | shares_owned_after: 1,433,019.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4
    • Sold 15,746 shares of stock options (to buy) at $31.4 per share (Derivative)
      Date: 2026-04-15 | Code: C | Expires: 2026-06-07 | equity_swap_involved: false | shares_owned_after: 1,417,273.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4

    Footnotes:

    • F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025.
    • F2: These options were issued in 2016 and are set to expire on June 7, 2026.
    • F3: The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016.
    • F4: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,417,273, 231,562 and 765,002, respectively.